Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Edner

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
JRSM Cardiovascular Disease|November 15, 2014
Health-related quality of life and long-term morbidity and mortality in patients hospitalised with systolic heart failureJenny Berg, Peter Lindgren, Thomas Kahan, et al.
International Journal of Cardiology|September 16, 2019
Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrumGianluigi Savarese, Åsa Jonsson, Ann-Charlotte Hallberg, et al.
Journal of Hypertension|September 1, 2007
Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)Richard Müller-Brunotte, Thomas Kahan, Begoña López, et al.
European Journal of Heart Failure|September 10, 2014
Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14,713 patients in the Swedish Heart Failure RegistryLars H Lund, Lina Benson, Marcus Ståhlberg, et al.
Patient Education and Counseling|July 13, 2005
A nurse-based management program in heart failure patients affects females and persons with cognitive dysfunction mostMonica Rydell Karlsson, Magnus Edner, Peter Henriksson, et al.
European Heart Journal|October 9, 2012
Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fractionLars H Lund, Juliane Jurga, Magnus Edner, et al.
Scandinavian Cardiovascular Journal : SCJ|July 1, 2014
Atrial fibrillation and biomarkers of myocardial fibrosis in heart failureJohan Löfsjögård, Hans Persson, Javier Díez, et al.
International Journal of Cardiology|August 7, 2015
Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fractionGianluigi Savarese, Magnus Edner, Ulf Dahlström, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 29, 2014
Gender, underutilization of cardiac resynchronization therapy, and prognostic impact of QRS prolongation and left bundle branch block in heart failureCecilia Linde, Marcus Ståhlberg, Lina Benson, et al.
Lipids|April 11, 2002
Cardiac and vascular structure and function are related to lipid peroxidation and metabolismPeter Steer, Jonas Millgård, Dennis M Sarabi, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
JRSM Cardiovascular Disease|November 15, 2014
Health-related quality of life and long-term morbidity and mortality in patients hospitalised with systolic heart failureJenny Berg, Peter Lindgren, Thomas Kahan, et al.
International Journal of Cardiology|September 16, 2019
Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrumGianluigi Savarese, Åsa Jonsson, Ann-Charlotte Hallberg, et al.
Journal of Hypertension|September 1, 2007
Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)Richard Müller-Brunotte, Thomas Kahan, Begoña López, et al.
European Journal of Heart Failure|September 10, 2014
Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14,713 patients in the Swedish Heart Failure RegistryLars H Lund, Lina Benson, Marcus Ståhlberg, et al.
Patient Education and Counseling|July 13, 2005
A nurse-based management program in heart failure patients affects females and persons with cognitive dysfunction mostMonica Rydell Karlsson, Magnus Edner, Peter Henriksson, et al.
European Heart Journal|October 9, 2012
Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fractionLars H Lund, Juliane Jurga, Magnus Edner, et al.
Scandinavian Cardiovascular Journal : SCJ|July 1, 2014
Atrial fibrillation and biomarkers of myocardial fibrosis in heart failureJohan Löfsjögård, Hans Persson, Javier Díez, et al.
International Journal of Cardiology|August 7, 2015
Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fractionGianluigi Savarese, Magnus Edner, Ulf Dahlström, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 29, 2014
Gender, underutilization of cardiac resynchronization therapy, and prognostic impact of QRS prolongation and left bundle branch block in heart failureCecilia Linde, Marcus Ståhlberg, Lina Benson, et al.
Lipids|April 11, 2002
Cardiac and vascular structure and function are related to lipid peroxidation and metabolismPeter Steer, Jonas Millgård, Dennis M Sarabi, et al.
Pageof 6